• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于血小板输血交叉配型的放射性标记抗球蛋白试验。

A radiolabeled antiglobulin test for crossmatching platelet transfusions.

作者信息

Kickler T S, Braine H G, Ness P M, Koester A, Bias W

出版信息

Blood. 1983 Feb;61(2):238-42.

PMID:6336957
Abstract

Despite the use of HLA-matched platelets for alloimmunized recipients, transfusion failures occur. In order to reduce these failures, we investigated the use of a radiolabeled antiglobulin technique for platelet crossmatching. The principle of the test is that of an indirect Coombs test using 125I labeled goat anti-human IgG. Incompatibility is determined by calculating a radioactivity antiglobulin test (RAGT) index. Using this technique, we performed 89 crossmatches on 19 leukemic or aplastic patients who were refractory to random donor platelets and receiving varying degrees of HLA-matched platelets. Effectiveness of the transfusion was assessed from the posttransfusion corrected platelet count increment (CCI) determined at 1 and 20 hr. When the RAGT index was 1.9 or less, the mean CCI at 1 lhr was 17,570 +/- 7003/cu mm, n = 55. When the RAGT index was 2.0 or greater, the mean CCI was 4237 +/- 4100/cu mm, n = 34. At 20 hr when the RAGT index was 1.9 or less, the mean CCI was 8722 +/- 3143/cu mm, n = 33, and when the index was 2.0 or greater, the mean CCI was 571 +/- 1286/cu mm, n = 23. Using this technique, one false negative resulted. Nine positive crossmatches with good increments at 1 hr were found; at 20 hr, however, the survival of these units was zero. These data suggest that this method is a useful adjunct in the selection of platelets in the refractory patient.

摘要

尽管为同种免疫受者使用了 HLA 匹配的血小板,但仍会出现输血失败的情况。为了减少这些失败,我们研究了使用放射性标记抗球蛋白技术进行血小板交叉配型。该测试的原理是使用 125I 标记的山羊抗人 IgG 的间接抗人球蛋白试验。通过计算放射性抗球蛋白试验(RAGT)指数来确定不相容性。使用该技术,我们对 19 名白血病或再生障碍性贫血患者进行了 89 次交叉配型,这些患者对随机供体血小板难治,且接受不同程度的 HLA 匹配血小板。输血效果通过输血后 1 小时和 20 小时测定的校正血小板计数增加值(CCI)进行评估。当 RAGT 指数为 1.9 或更低时,1 小时时的平均 CCI 为 17,570±7003/立方毫米,n = 55。当 RAGT 指数为 2.0 或更高时,平均 CCI 为 4237±4100/立方毫米,n = 34。在 20 小时时,当 RAGT 指数为 1.9 或更低时,平均 CCI 为 8722±3143/立方毫米,n = 33,当指数为 2.0 或更高时,平均 CCI 为 571±1286/立方毫米,n = 23。使用该技术产生了 1 例假阴性结果。发现 9 次交叉配型为阳性,1 小时时增量良好;然而,在 20 小时时,这些单位的存活率为零。这些数据表明,该方法在难治性患者血小板选择中是一种有用的辅助手段。

相似文献

1
A radiolabeled antiglobulin test for crossmatching platelet transfusions.一种用于血小板输血交叉配型的放射性标记抗球蛋白试验。
Blood. 1983 Feb;61(2):238-42.
2
Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.酶联免疫分析血小板交叉配型对血小板浓缩物输注给同种免疫受者的预测价值。
Am J Hematol. 1987 Apr;24(4):375-87. doi: 10.1002/ajh.2830240407.
3
Prospective platelet crossmatching for selection of compatible random donors.用于选择相容随机供者的前瞻性血小板交叉配型
Br J Haematol. 1984 Jan;56(1):9-18. doi: 10.1111/j.1365-2141.1984.tb01267.x.
4
Random donor platelet crossmatching: comparison of four platelet antibody detection methods.
Am J Hematol. 1988 May;28(1):1-7. doi: 10.1002/ajh.2830280102.
5
Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.血小板交叉配型:为同种免疫性血小板减少症患者选择血小板输注的直接方法。
Am J Clin Pathol. 1988 Jul;90(1):69-72. doi: 10.1093/ajcp/90.1.69.
6
[Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].[血小板输注:与临床和免疫学前提条件相关的血小板增加情况]
Infusionsther Klin Ernahr. 1987 Apr;14 Suppl 2:10-4.
7
An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.对难治性患者血小板输注的交叉配血、人类白细胞抗原(HLA)配型及ABO血型配型的评估。
Blood. 1987 Jul;70(1):23-30.
8
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.
9
Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.交叉配型相容的血小板可提高对随机选择的血小板无效的患者的校正计数增加值。
Blood Transfus. 2014 Apr;12(2):180-6. doi: 10.2450/2013.0064-13. Epub 2013 Nov 14.
10
The predictive value of crossmatching platelet transfusion for alloimmunized patients.
Transfusion. 1985 Jul-Aug;25(4):385-9. doi: 10.1046/j.1537-2995.1985.25485273823.x.

引用本文的文献

1
Evaluation of platelet cross-matching in the management of patients refractory to platelet transfusions.血小板交叉配型在血小板输注难治性患者管理中的评估。
Blood Transfus. 2014 Apr;12(2):187-94. doi: 10.2450/2014.0120-13.
2
The use of blood components in patients with malignancy.
World J Surg. 1987 Feb;11(1):20-4. doi: 10.1007/BF01658454.